☰

Michelle I. Vitolo - Publications

Affiliations: 
2007-2008 Biochemistry & Molecular Biology University of Maryland School of Medicine, Baltimore, MD, United States 
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pratt SJP, Lee RM, Chang KT, Hernández-Ochoa EO, Annis DA, Ory EC, Thompson KN, Bailey PC, Mathias TJ, Ju JA, Vitolo MI, Schneider MF, Stains JP, Ward CW, Martin SS. Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca signals that are inhibited by oncogenic KRas. Proceedings of the National Academy of Sciences of the United States of America. PMID 33020304 DOI: 10.1073/pnas.2009495117  0.399
2020 Pratt SJ, Lee RM, Hernandez-Ochoa EO, Ory EC, Thompson KN, Bailey PC, Mathias TJ, Ju JA, Vitolo MI, Schneider MF, Stains JP, Ward CW, Martin SS. Abstract 2575: Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca2+ signals that are inhibited by oncogenic KRas Immunology. 80: 2575-2575. DOI: 10.1158/1538-7445.Am2020-2575  0.415
2018 Pratt SJP, Hernández-Ochoa EO, Lee RM, Ory EC, Lyons JS, Joca HC, Johnson A, Thompson K, Bailey P, Lee CJ, Mathias T, Vitolo MI, Trudeau M, Stains JP, Ward CW, et al. Real-time scratch assay reveals mechanisms of early calcium signaling in breast cancer cells in response to wounding. Oncotarget. 9: 25008-25024. PMID 29861849 DOI: 10.18632/Oncotarget.25186  0.402
2018 Linthicum W, Thanh MH, Vitolo MI, Wen Q. Effects of PTEN Loss and Activated KRAS Overexpression on Mechanical Properties of Breast Epithelial Cells. International Journal of Molecular Sciences. 19. PMID 29848992 DOI: 10.3390/Ijms19061613  0.429
2018 Yu Y, Suryo Rahmanto Y, Lee MH, Wu PH, Phillip JM, Huang CH, Vitolo MI, Gaillard S, Martin SS, Wirtz D, Shih IM, Wang TL. Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway. Oncogene. PMID 29643476 DOI: 10.1038/S41388-018-0241-0  0.497
2016 Hessler LK, Boggs AE, Whipple RA, Vitolo MI, Chakrabarti KR, Bhandary L, Thompson KN, Martin SS. Abstract LB-342: HDAC inhibition promotes tubulin-independent cancer cell migration Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-342  0.306
2015 Thompson KN, Whipple RA, Yoon JR, Lipsky M, Charpentier MS, Boggs AE, Chakrabarti KR, Bhandary L, Hessler LK, Martin SS, Vitolo MI. The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence. Oncotarget. PMID 26497685 DOI: 10.18632/Oncotarget.6159  0.372
2015 Chakrabarti KR, Whipple RA, Boggs AE, Hessler LK, Bhandary L, Vitolo MI, Thompson K, Martin SS. Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and re-attachment. Oncotarget. PMID 26431377 DOI: 10.18632/Oncotarget.5345  0.311
2015 Bhandary L, Whipple RA, Vitolo MI, Charpentier MS, Boggs AE, Chakrabarti KR, Thompson KN, Martin SS. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells. Oncotarget. 6: 6251-66. PMID 25749040 DOI: 10.18632/Oncotarget.3360  0.332
2015 Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis Oncogene. 34: 4248-4259. PMID 25381817 DOI: 10.1038/Onc.2014.358  0.337
2015 Thompson KN, Whipple RA, Charpentier MS, Boggs AE, Bhandray L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract A32: Cell dormancy and tumorigenicity due to PTEN loss Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-A32  0.375
2015 Thompson KN, Whipple RA, Yoon JR, Charpentier MS, Boggs AE, Bhandary L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract 2161: Activation of the MAPK pathway in combination with PTEN loss leads to aggressive primary tumor formation Cancer Research. 75: 2161-2161. DOI: 10.1158/1538-7445.Am2015-2161  0.39
2014 Perry NA, Vitolo MI, Martin SS, Kontrogianni-Konstantopoulos A. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells. Oncotarget. 5: 8558-68. PMID 25261370 DOI: 10.18632/Oncotarget.2338  0.409
2014 Hartman KG, Vitolo MI, Pierce AD, Fox JM, Shapiro P, Martin SS, Wilder PT, Weber DJ. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK. The Journal of Biological Chemistry. 289: 12886-95. PMID 24627490 DOI: 10.1074/Jbc.M114.561613  0.662
2014 Bhandary L, Vitolo MI, Bettes RA, Charpentier MS, Boggs AE, Slovic J, Thompson K, Martin SS. Abstract 3160: ROCK inhibition promotes microtentacle formation and reattachment of breast cancer cells Cancer Research. 74: 3160-3160. DOI: 10.1158/1538-7445.Am2014-3160  0.423
2013 Vitolo MI, Boggs AE, Whipple RA, Yoon JR, Thompson K, Matrone MA, Cho EH, Balzer EM, Martin SS. Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin. Oncogene. 32: 2200-10. PMID 22689060 DOI: 10.1038/Onc.2012.234  0.391
2013 Slovic J, Vitolo MI, Whipple RA, Boggs AE, Charpentier MS, Bhandary L, Thompson K, Martin SS. Abstract 276: Microtentacle stabilization during TGFβ-induced EMT as a new therapeutic target to reduce circulating tumor cell metastasis. Cancer Research. 73: 276-276. DOI: 10.1158/1538-7445.Am2013-276  0.347
2012 Pierce AD, Anglin IE, Vitolo MI, Mochin MT, Underwood KF, Goldblum SE, Kommineni S, Passaniti A. Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype. Journal of Cellular Biochemistry. 113: 282-92. PMID 21913213 DOI: 10.1002/Jcb.23354  0.378
2012 Hartman KG, Vitolo MI, Wilder PT, Fox J, Shapiro P, Martin SS, Weber DJ. Abstract 2164: S100B affects MAPK signaling in malignant melanoma via a direct interaction with RSK Cancer Research. 72: 2164-2164. DOI: 10.1158/1538-7445.Am2012-2164  0.676
2011 House RP, Pozzuto M, Patel P, Dulyaninova NG, Li ZH, Zencheck WD, Vitolo MI, Weber DJ, Bresnick AR. Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion. Biochemistry. 50: 6920-32. PMID 21721535 DOI: 10.1021/Bi200498Q  0.541
2011 Li HF, Keeton A, Vitolo M, Maddox C, Rasmussen L, Hobrath J, White EL, Park BH, Piazza GA, Kim JS, Waldman T. A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. Journal of Biomolecular Screening. 16: 383-93. PMID 21335596 DOI: 10.1177/1087057110397357  0.316
2011 Vitolo MI, Boggs AE, Thompson K, Whipple RA, Yoon JR, Slovic J, Charpentier MS, Matrone MA, Martin SS. Abstract 3122: PTEN loss disrupts the actin cortex to promote tubulin microtentacle formation and increased metastatic potential Cancer Research. 71: 3122-3122. DOI: 10.1158/1538-7445.Am2011-3122  0.356
2011 Gianni K, Vitolo MI, Wilder PT, Martin SS, Weber DJ. Abstract 1054: S100B affects cell signaling in malignant melanoma Cancer Research. 71: 1054-1054. DOI: 10.1158/1538-7445.Am2011-1054  0.79
2010 Weiss MB, Vitolo MI, Mohseni M, Rosen DM, Denmeade SR, Park BH, Weber DJ, Bachman KE. Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response. Oncogene. 29: 4715-24. PMID 20562907 DOI: 10.1038/Onc.2010.220  0.638
2010 Gianni K, Wilder PT, Vitolo MI, Shapiro P, Weber DJ. Abstract 4125: The effects of S100B on cell signaling in malignant melanoma Cancer Research. 70: 4125-4125. DOI: 10.1158/1538-7445.Am10-4125  0.779
2009 Higgins MJ, Abukhdeir AM, Gustin J, Vitolo MI, Bachman KE, Park BH. Preclinical study of lithium sensitivity in human breast PTEN knock out cell lines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e14641. PMID 27964232 DOI: 10.1200/Jco.2009.27.15_Suppl.E14641  0.36
2009 Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, Park BH, Martin SS, Weber DJ, Bachman KE. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Research. 69: 8275-83. PMID 19843859 DOI: 10.1158/0008-5472.Can-09-1067  0.698
2009 Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, Mohseni M, Wang G, Rosen DM, Denmeade SR, Higgins MJ, ... Vitolo MI, et al. Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proceedings of the National Academy of Sciences of the United States of America. 106: 2835-40. PMID 19196980 DOI: 10.1073/Pnas.0813351106  0.649
2008 Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, Konishi H, Gustin JP, Lauring J, Garay JP, Pendleton C, Konishi Y, Blair BG, Brenner K, Garrett-Mayer E, Carraway H, et al. Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proceedings of the National Academy of Sciences of the United States of America. 105: 288-93. PMID 18162533 DOI: 10.1073/Pnas.0710887105  0.308
2007 Vitolo MI, Anglin IE, Mahoney WM, Renoud KJ, Gartenhaus RB, Bachman KE, Passaniti A. The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biology & Therapy. 6: 856-63. PMID 17438369 DOI: 10.4161/Cbt.6.6.4241  0.339
2007 Weiss MB, Vitolo MI, Baerenfaller K, Marra G, Park BH, Bachman KE. Persistent mismatch repair deficiency following targeted correction of hMLH1. Cancer Gene Therapy. 14: 98-104. PMID 17082796 DOI: 10.1038/Sj.Cgt.7700997  0.588
2004 Sun L, Vitolo MI, Qiao M, Anglin IE, Passaniti A. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells. Oncogene. 23: 4722-34. PMID 15107836 DOI: 10.1038/Sj.Onc.1207589  0.325
2003 Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene. 22: 2334-42. PMID 12700668 DOI: 10.1038/Sj.Onc.1206330  0.33
Show low-probability matches.